Active, Not Recruiting
Durvalumab and Tremelimumab in Treating Patients With Muscle-Invasive, High-Risk Urothelial Cancer That Cannot Be Treated With Cisplatin-Based Therapy Before Surgery
NCT02812420
- Conditions
- Female Urogenital Diseases, Female Urogenital Diseases and Pregnancy Complications, Hydronephrosis, +30 more
- Locations
-
- M D Anderson Cancer Center Houston, Texas, United States